The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Svechnikova E.V.

Medical Institute of Continuing Education of Rosbiotech;
Polyclinic No. 1 of Administrative Directorate of the President of the Russian Federation

Merzlikina N.A.

Polyclinic No. 1 of Administrative Directorate of the President of the Russian Federation

The skin we live in

Authors:

Svechnikova E.V., Merzlikina N.A.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(4): 34‑36

Read: 237 times

To cite this article:

Svechnikova EV, Merzlikina NA. The skin we live in. Non Nocere. New Therapeutic Journal. 2025;(4):34‑36. (In Russ.)

References:

  1. Borovik T.E., Makarova S.G., Darchiya S.N., Gamaleeva A.V., Gribakin S.G. Skin as an organ of the immune system. Pediatrics. 2010;2:10-18. 
  2. Schittek B, Paulmann M, Senyürek I, Steffen H. The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets. 2008 Sep; 8(3):135-143.  https://doi.org/10.2174/1871526510808030135
  3. Yamasaki K, Gallo RL. Antimicrobial peptides in human skin disease. Eur J Dermatol. 2008 Jan–Feb;18(1):11-21.  https://doi.org/10.1684/ejd.2008.0304
  4. Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol. 2009 Jan;16(1):41-47.  https://doi.org/10.1097/moh.0b013e32831ac517
  5. Ma Z., Kochergin N.G. Antibacterial peptides in the treatment of acne vulgaris patients. Russian Journal of Skin and Venereal Diseases. 2019;22(5-6):185-191.  https://doi.org/10.17816/dv42957
  6. Harder J, Dressel S, Wittersheim M, et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol. 2010 May;130(5):1355-1364. https://doi.org/10.1038/jid.2009.432
  7. Svirshchevskaia EV, Matushevskaia EV. Role of lipids in skin barrier properties. Russian Journal of Clinical Dermatology and Venereology. 2019;18(3):360-365. (In Russ.) https://doi.org/10.17116/klinderma201918031360
  8. Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis – Part I: Clinical and pathologic concepts. J Allergy Clin Immunol. 2011 May;127(5):1110-1118. https://doi.org/10.1016/j.jaci.2011.01.053
  9. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011 Oct 6;365(14):1315-1327. https://doi.org/10.1056/NEJMra1011040
  10. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am. 2010 Aug;30(3):269-280.  https://doi.org/10.1016/j.iac.2010.06.003
  11. Ong PY, Leung DY. Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review. Clin Rev Allergy Immunol. 2016 Dec;51(3):329-337.  https://doi.org/10.1007/s12016-016-8548-5
  12. Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013 Jun;62(2):151-161.  https://doi.org/10.2332/allergolint.13-RAI-0564
  13. Mack MR, Kim BS. The Itch – Scratch Cycle: A Neuroimmune Perspective. Trends Immunol. 2018 Dec;39(12):980-991.  https://doi.org/10.1016/j.it.2018.10.001
  14. Sanj S. Psoriasis as a barrier disease. Dermatologica Sinica. 2015;33:64-69.  https://doi.org/10.1016/j.tig.2010.06.006
  15. Bergboer JGM, Zeeuwen PLJM, Schalkwijk J. Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. J Invest Dermatol. 2012 Oct;132(10):2320-2331. https://doi.org/10.1038/jid.2012.167
  16. Reinholz M, Ruzicka T, Schauber J. Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol. 2012 May;24(2):126-135.  https://doi.org/10.5021/ad.2012.24.2.126
  17. Denieva MI, Mildzikhova DR, Dvoryankova EV. Secondary infection in psoriasis patients. Russian Journal of Clinical Dermatology and Venereology. 2021;20(6):113-118. (In Russ.) https://doi.org/10.17116/klinderma202120061113
  18. Kruglova L.S., Pereverzina N.O. Risks of Infectious Diseases in Psoriasis Patients Treated with Biological Agents: Original Study. Effective pharmacotherapy. 2024;20(1):6-16.  https://doi.org/10.33978/2307-3586-2024-20-1-6-16
  19. Piruzyan AL, Mildzikhova DR, Sakaniya LR, Korsunskaya IM. Aging changes in skin: causes and effects. Meditsinskiy sovet = Medical Council. 2023;(2):8-12. (In Russ.) https://doi.org/10.21518/ms2023-027
  20. Markelova EV, Iutskovskaia IaA, Birko ON, Baibarina EV, Chepurnova NS. The immune system of the skin: the age peculiarities. Russian Journal of Clinical Dermatology and Venereology. 2016;15(6):4-10. (In Russ.) https://doi.org/10.17116/klinderma20161564-10
  21. Shirinsky V.S., Shirinsky I.V. Polymorbidity, ageing of immune system and low-grade systemic inflammation: a challenge for modern medicine. Medical Immunology (Russia). 2020;22(4):609-624. (In Russ.) https://doi.org/10.15789/1563-0625-PAO-2042
  22. Petrova S.Y., Albanova V.I. Barrier function of the skin and the role of fat-soluble vitamins in the correction of its disorders. Vestnik dermatologii i venerologii. 2022;98(3):24-33.  https://doi.org/10.25208/vdv1313

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.